International Journal of Drug Policy
Volume 21, Issue 1 , Pages 10-19 , January 2010

Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies

  • Jennifer A. McLaren

      Affiliations

    • National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Australia
    • ,
  • Edmund Silins

      Affiliations

    • National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 02 9385 0141; fax: +61 02 9385 0222.
    • ,
  • Delyse Hutchinson

      Affiliations

    • National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Australia
    • ,
  • Richard P. Mattick

      Affiliations

    • National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Australia
    • ,
  • Wayne Hall

      Affiliations

    • School of Population Health, University of Queensland, QLD 4006, Australia

Received 6 May 2009 ,Revised 17 August 2009 ,Accepted 8 September 2009.

References 

  1. Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. American Journal of Drug and Alcohol Abuse. 2002;28:643
  2. American Psychiatric Association . Diagnostic and statistical manual of mental disorders, 4th ed., text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000;
  3. Ames F. A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. Journal of Mental Science. 1958;104:972–999
  4. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet. 1987;330:1483–1486
  5. Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases. British Journal of Psychiatry. 2005;187:510–515
  6. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt T. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal. 2002;325:1212–1213
  7. Arseneault L, Cannon M, Witton J, Murray R. Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry. 2004;184:110–117
  8. Benichou J. Attributable risk. In:  Armitage P,  Colton T editor. Encyclopedia of biostatistics. Chichester: Wiley; 1998;
  9. Boden JM, Fergusson DM, Horwood LJ. Illicit drug use and dependence in a New Zealand birth cohort. Australian and New Zealand Journal of Psychiatry. 2006;40:156–163
  10. Brophy CJ, Norvell NK, Kiluk DJ. An examination of the factor structure and convergent and discriminant validity of the SCL-90R in an outpatient clinic population. Journal of Personality Assessment. 1988;52:334–340
  11. Caspi A, Moffitt T, Cannon M, McClay J, Murray R, Harrington H, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-o-methyltransferase gene: Longitudinal evidence of a gene×environment interaction. Biological Psychiatry. 2005;57:1117–1127
  12. Chopra G, Smith J. Psychotic reactions following cannabis use in East Indians. Archives of General Psychiatry. 1974;30:24–27
  13. Curran C, Byrappa N, McBride A. Stimulant psychosis: Systematic review. British Journal of Psychiatry. 2004;185:196–204
  14. Daly LE, Bourke GJ. Interpretation and uses of medical statistics. Oxford: Blackwell Science; 2000;
  15. Degenhardt L, Hall W. The association between psychosis and problematic drug use among Australian adults: Findings from the National Survey of Mental Health and Well-being. Psychological Medicine. 2001;31:659–668
  16. Degenhardt, L., Hall, W., & Lynskey, M. (2001). Modelling some possible relationships between cannabis use and psychosis. NDARC Technical Report no. 121. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
  17. Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence. 2003;71:37–48
  18. de Irala J, Ruiz-Canela M, Martinez-Gonzalez M. Causal relationship between cannabis use and psychotic symptoms or depression, Should we wait and see? A public health perspective. Medical Science Monitor. 2005;11(12):RA355–358
  19. Diamond G, Godley S, Liddle H, Sampl S, Webb C, Tims F, et al. Five outpatient treatment models for adolescent marijuana use: A description of the Cannabis Youth Treatment Interventions. Addiction. 2002;97:70–83
  20. Di Maggio C, Martinez M, Menard J-F, Petit M, Thibaut F. Evidence of a cohort effect for age at onset of schizophrenia. American Journal of Psychiatry. 2001;158:489–492
  21. D'Souza D, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu Y, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology. 2004;29:1558–1572
  22. Dwyer T, Ponsonby A-L, Blizzard L, Newman N, Cochrane J. The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. Obstetrical and Gynecological Survey. 1995;50(10):704–705
  23. Elliot R, Fox CM, Beltyukova SA, Stone GE, Gunderson J, Zhang X. Deconstructing therapy outcome measurement with rasch analysis of a measure of general clinical distress: The Symptom Checklist-90-Revised. Psychological Assessment. 2006;18:359–372
  24. Favrat B, Menetrey A, Augsburger M, Rothuizen LE, Appenzeller M, Buclin T, et al. Two cases of “cannabis acute psychosis” following the administration of oral cannabis. BMC Psychiatry. 2005;5(17):
  25. Fergusson DM, Boden J, Horwood LJ. Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction. 2006;101:556–569
  26. Fergusson DM, Horwood L. Does cannabis use encourage other forms of illicit drug use?. Addiction. 2000;95:505–520
  27. Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction. 2005;100:354–366
  28. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Pychological Medicine. 2003;33:15–21
  29. Frisher M, Crome I, Martino O, Croft P. Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. Schizophrenia Research. 2009;113(2–3):123–128
  30. Hall W. Cannabis use and the mental health of young people. Australian and New Zealand Journal of Psychiatry. 2006;40:105–113
  31. Hall W. Is cannabis use psychotogenic?. Lancet. 2006;367:193–195
  32. Hall W, Degenhardt L. What are the policy implications of the evidence on cannabis and psychosis?. Canadian Journal of Psychiatry. 2006;51:566–574
  33. Hall W, Degenhardt L, Teesson M. Cannabis use and psychotic disorders: An update. Drug and Alcohol Review. 2004;23:433–443
  34. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal. 2005;330:11
  35. Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: The role of cannabis use. Schizophrenia Bulletin. 2005;31:608–612
  36. Hides L, Dawe S, Kavanagh D, Young RM. Psychotic symptoms and cannabis relapse in recent-onset psychosis: Prospective study. British Journal of Psychiatry. 2006;189:137–143
  37. Hill AB. A short textbook of statistics. London: Hodder and Stoughton; 1977;
  38. Hill AB, Hill ID. Principles of medical statistics. 12th ed.. London: Edward Arnold; 1991;
  39. Johns LC, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T, et al. Prevalence and correlates of self-reported psychotic symptoms in the British population. British Journal of Psychiatry. 2004;185:298–305
  40. Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clinical Psychology Review. 2001;21:1125–1141
  41. Kavanagh D, Waghorn G, Jenner L, Chant D, Carr V, Evans M, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. Schizophrenia Research. 2004;66:115–124
  42. Kendell R, Malcolm DE, Adams W. The problem of detecting changes in the incidence of schizophrenia. British Journal of Psychiatry. 1993;162:212–218
  43. Klein D. The flawed basis for FDA post-marketing safety decisions: The example of anti-depressants and children. Neuropsychopharmacology. 2006;31:689–699
  44. Linszen D, Peters B, de Haan L. Cannabis abuse and the course of schizophrenia. In:  Castle D,  Murray R editor. Marijuana and madness: Psychiatry and neurobiology. Cambridge, United Kingdom: Cambridge University Press; 2004;p. 119–126
  45. Macleod J, Davey Smith G. Psychosocial factors and public health: A suitable case for treatment?. Journal of Epidemiology and Community Health. 2003;57:565–570
  46. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet. 2004;363:1579–1588
  47. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. The Lancet. 2004;363(9421):1579–1588
  48. Macleod J, Smith G, Hickman M. Does cannabis cause schizophrenia?. Lancet. 2006;367:1055
  49. Mattick R, McLaren J. Cannabis and psychosis put in perspective. Canadian Journal of Psychiatry. 2006;51(9):13–14
  50. McGorry PD. The detection and optimal management of early psychosis. In:  Lieberman JA,  Murray R editor. Comprehensive care of schizophrenia: A textbook of clinical management. London: Informa Health Care; 2001;p. 153–166
  51. McKetin R, McLaren J, Lubman D, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006;101:1473–1478
  52. Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet. 2007;370:319–328
  53. Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O, et al. Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine. 1999;340:603–608
  54. Nunez L, Gurpegui M. Cannabis-induced psychosis: A cross-sectional comparison with acute schizophrenia. Acta Psychiatrica Scandinavica. 2002;105:173–178
  55. Poulton R, Caspi A, Moffitt T, Cannon M, Murray R, Harrington H. Children's self-reported psychotic symptoms predict adult schizophreniform disorders: A 15-year longitudinal study. Archives of General Psychiatry. 2000;57:1053–1058
  56. Reinarman C, Cohen P. Lineaments of cannabis culture: Rules regulating use in Amsterdam and San Francisco. Contemporary Justice Review. 2007;10(4):393–410
  57. Reinarman C, Cohen P, Kaal HL. The limited relevance of drug policy: Cannabis in Amsterdam and in San Fransisco. American Journal of Public Health. 2004;94:836–842
  58. Rey J, Tennant C. Cannabis and mental health. British Medical Journal. 2002;325:1183–1184
  59. Rosenbaum M. “Just say know” to teenagers and marijuana. Journal of HIV/AIDS Prevention in Children and Youth. 2000;3(4):93–105
  60. Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: Systematic review. Journal of Psychopharmacology. 2005;19:187
  61. Smit F, Bolier L, Cuijpers P. Cannabis use and the risk of later schizophrenia: A review. Addiction. 2004;99:425–430
  62. Smith GD, Ebrahim S. Data dredging, bias, or confounding. British Medical Journal. 2002;325:1437–1438
  63. Solomons K, Neppe V, Kuyl J. Toxic cannabis psychosis is a valid entity. South African Medical Journal. 1990;78:476–481
  64. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction. 2004;99:1333–1341
  65. Teesson M, Hall W, Lynskey M, Degenhardt L. Alcohol- and drug-use disorders in Australia: Implications of the national survey of mental health and wellbeing. Australian & New Zealand Journal of Psychiatry. 2000;34(2):206–213
  66. Thomas H. A community survey of adverse effects of cannabis use. Drug and Alcohol Dependence. 1996;42:201–207
  67. Thornicroft G. Cannabis and psychosis: Is there epidemiological evidence for an association?. British Journal of Psychiatry. 1990;157:25–33
  68. Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease. 1990;178:473–480
  69. Tugwell P, Haynes B. Assessing claims of causation. In:  Haynes B,  Sackett DL,  Guyatt GH,  Tugwell P editor. Clinical epidemiology: How to do clinical practice research. Philadelphia: Lippincott Williams and Wilkins; 2006;p. 356–387
  70. van Os J, Bak M, Hanssen M, Bijl R, de Graaf R, Verdoux H. Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology. 2002;156:319–327
  71. Veen ND, Selten JP, van der Tweel I, Feller W, Hoek HW, Kahn RS. Cannabis use and age at onset of schizophrenia. American Journal of Psychiatry. 2004;161:501–506
  72. Wetzler S, Marlowe DB. The diagnosis and assessment of depression, mania, and psychosis by self-report. Journal of Personality Assessment. 1993;60:1–31
  73. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population. British Journal of Psychiatry. 2006;188:519–526
  74. Wylie A, Scott R, Burnett S. Psychosis due to “skunk”. British Medical Journal. 1995;311:125
  75. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. British Medical Journal. 2002;325:1199–1201
  76. Zammit S, Spurlock G, Williams H, Norton N, Williams N, O’Donovan MC. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: Interactions with tobacco and cannabis use. British Journal of Psychiatry. 2007;191:402–407

PII: S0955-3959(09)00118-2

doi: 10.1016/j.drugpo.2009.09.001

International Journal of Drug Policy
Volume 21, Issue 1 , Pages 10-19 , January 2010

Article Tools